60732 Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 

Survey (FACES), the National Head 

Start Impact Study, Head Start’s 

Performance-Based Outcome System, 

and the ongoing evaluation of the Early 

Head Start program. 

DATES: October 27, 2006, 8:30 a.m.–5 

p.m. 

Place: The Westin Embassy Row 

Hotel, 2100 Massachusetts Avenue, 

NW., Washington, DC 20008. 

Agenda: The Committee will continue 

the discussions begun at previous 

Committee meetings. 

SUPPLEMENTARY INFORMATION: This, the 

fourth meeting of the Committee, is 

open to the public. Persons wishing to 

bring written statements or papers 

focused on relevant, existing research 

with Head Start populations or on 

measures appropriate for low-income 

four- and five-year old children are 

welcome to do so. Individuals may 

e-mail such documents to 

Secretaryadvisory-hs@esi-dc.com or 

mail to: ESI, ATTN: Townley Knudson, 

Head Start Secretary’s Advisory 

Committee, 1150 Connecticut Avenue, 

NW., Suite 1100, Washington, DC 

20036. 

Documents received shall be 

presented to the Committee. The 

Committee meeting records shall be 

kept at the Aerospace Center located at 

901 D Street, SW., Washington, DC 

20447. The Committee’s charter, past 

meeting agendas, meeting proceedings 

and materials related to this meeting can 

be found at: http://www.acf.hhs.gov/ 

programs/hsb/budget/AdvCmteSep05/ 

index.htm. 

An interpreter for the deaf and hardof-hearing, will be available upon 

advance request by contacting 

Secretaryadvisory-hs@esi-dc.com. 

Due to a clerical error at the 

Administration for Children and 

Families, this meeting notice may be 

published less than 15 days prior to the 

meeting. 

Dated: October 10, 2006. 

Robert A. Sargis, 

Reports Clearance Officer. 

[FR Doc. 06–8671 Filed 10–13–06; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–06–8404] 

Memorandum of Understanding 

Between the Food and Drug 

Administration, and Duke University 

for the Cardiac Safety Research 

Consortium 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between FDA and 

Duke University, on behalf of its Duke 

Clinical Research Institute (DCRI). FDA 

and Duke University agree to collaborate 

under the terms and conditions of this 

MOU, through steering committees and 

technical working groups, to develop 

strategic plans, set priorities, and 

leverage resources and expertise from 

multiple sources, including the private 

sector, toward the goals of identifying 

indicators of cardiovascular risk, 

predicting adverse cardiovascular 

events associated with therapeutic 

interventions, improving the clinical 

utility of biomarker technologies as 

diagnostic and assessment tolls that 

facilitate the development of safer and 

more effective cardiovascular therapies, 

diagnostic, and assessment tools. This 

collaboration between the Parties shall 

be known as the Cardiac Safety 

Research Consortium. 

DATES: The agreement became effective 

August 15, 2006. 

FOR FURTHER INFORMATION CONTACT: 

For FDA: Wendy R. Sanhai, Office of 

the Commissioner (HF–18), Food 

and Drug Administration, 5600 

Fishers Lane, 14B–45, Rockville, 

MD 20857, 301–827–7867, FAX: 

301–443–9718, 

wendy.sanhai@fda.hhs.gov. 

For Duke Clinical Research Institute: 

Christopher H. Cabell, Department 

of Medicine, Duke University 

School of Medicine, DUMC Box 

2705, Durham, NC 27705, 919–668–

8611, FAX: 919–668–7066, 

chris.cabell@duke.edu. 

For Duke: Office of Research 

Administration, Duke University 

Medical Center, 2424 Erwin Rd., 

suite 1103, Durham, NC 27705, 

919–684–5175, FAX: 919–684–

6278. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: October 6, 2006. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 60733 


jlentini on PROD1PC65 with NOTICESEN16OC06.000</GPH>
60734 Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 


jlentini on PROD1PC65 with NOTICESEN16OC06.001</GPH>
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 60735 


jlentini on PROD1PC65 with NOTICESEN16OC06.002</GPH>
60736 Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 


jlentini on PROD1PC65 with NOTICESEN16OC06.003</GPH>
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 60737 


jlentini on PROD1PC65 with NOTICESEN16OC06.004</GPH>
60738 Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 


jlentini on PROD1PC65 with NOTICESEN16OC06.005</GPH>
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices 60739 

[FR Doc. 06–8708 Filed 10–13–06; 8:45 am] 

BILLING CODE 4160–01–C 


jlentini on PROD1PC65 with NOTICESEN16OC06.006</GPH>